China Pharmaceutical Sector Report 2016 4th Quarter
An EMIS Insights Industry ReportEMIS is an ISI Emerging Markets Group Company Date: March 2017
Pages: 65
Available in: English
China is the world’s second-largest pharmaceutical market, after the US, and the largest producer and exporter of active pharmaceutical ingredients (APIs) globally. Since it is the world’s most populous country, with a large ageing population, the healthcare and pharmaceutical industries are of key importance to the government, which has launched a series of reforms in both sectors during the last few years.
This report provides a complete and detailed analysis of the pharmaceutical sector for China. EMIS Insights presents in-depth business intelligence in a standard format across countries and regions, providing a balanced mix between analysis and data.
What this report allows you to do:
- Understand the key elements at play in the pharmaceutical sector in China
- Access forecasts for growth in the sector
- View key data on production and sales for the sector in China
- Crystallise the forces both driving and restraining this sector in China
- Build a complete perspective on sector trade, investment and employment
- Understand the competitive landscape and who the major players are
- View M&A activity and major deals
- Gain an understanding of the regulatory environment for the sector in China
- Build a clear picture of trends and issues for sub-sectors (western medicine, traditional Chinese medicine)
See below for a complete table of report contents:
Email us at: emisstoresupport@emis.com